Global Antibody Production Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 16-Sep-2022
No. of pages: 102
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antibody Production manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Antibody Production market. Further, it explains the major drivers and regional dynamics of the global Antibody Production market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Thermo Fisher Scientific, Inc.

- GE Healthcare

- Sartorius AG

- Merck KGaA

- Eppendorf AG

- Cellab GmbH

- Pall Corp.

- INTEGRA Biosciences AG

- FiberCell Systems Inc.

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Antibody Production Segment by Type

- Polyclonal antibody

- Monoclonal antibody

- Murine

- Chimeric

- Humanized

Antibody Production Segment by Application

- Pharmaceutical and biotechnology companies

- Research laboratories

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Antibody Production market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Antibody Production, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Antibody Production, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Antibody Production, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody Production sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Antibody Production market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Antibody Production sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG and FiberCell Systems Inc., etc.

Global Antibody Production Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Antibody Production Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Polyclonal antibody
1.2.3 Monoclonal antibody
1.2.4 Murine
1.2.5 Chimeric
1.2.6 Humanized
1.3 Market Segment by Application
1.3.1 Global Antibody Production Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Pharmaceutical and biotechnology companies
1.3.3 Research laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Antibody Production Market Size (2017-2028)
2.1.1 Global Antibody Production Revenue (2017-2028)
2.1.2 Global Antibody Production Sales (2017-2028)
2.2 Global Antibody Production Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Antibody Production Sales by Regions (2017-2022)
2.2.2 Global Antibody Production Revenue by Regions (2017-2022)
2.3 Global Antibody Production Market Size Forecast by Region
2.3.1 Global Antibody Production Sales Forecast by Region (2023-2028)
2.3.2 Global Antibody Production Revenue Forecast by Region (2023-2028)
2.4 Global Top Antibody Production Regions (Countries) Ranking by Market Size
2.5 Antibody Production Market Dynamics
2.5.1 Antibody Production Market Trends
2.5.2 Antibody Production Market Drivers
2.5.3 Antibody Production Market Challenges
2.5.4 Antibody Production Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Antibody Production Manufacturers by Sales (2017-2022)
3.1.1 Global Antibody Production Sales by Manufacturers (2017-2022)
3.1.2 Global Antibody Production Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Antibody Production Sales in 2021
3.2 Global Top Manufacturers Antibody Production by Revenue
3.2.1 Global Antibody Production Revenue by Manufacturers (2017-2022)
3.2.2 Top Antibody Production Manufacturers Covered: Ranking by Revenue
3.2.3 Global Antibody Production Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Antibody Production Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Production as of 2021)
3.4 Global Antibody Production Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Antibody Production Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Antibody Production Market
3.7 Key Manufacturers Antibody Production Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Antibody Production Market Size by Type
4.1 Global Antibody Production Historic Market Review by Type (2017-2022)
4.1.1 Global Antibody Production Sales Market Share by Type (2017-2022)
4.1.2 Global Antibody Production Revenue Market Share by Type (2017-2022)
4.1.3 Antibody Production Price by Type (2017-2022)
4.2 Global Antibody Production Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Antibody Production Sales Forecast by Type (2023-2028)
4.2.2 Global Antibody Production Revenue Forecast by Type (2023-2028)
4.2.3 Antibody Production Price Forecast by Type (2023-2028)
5 Global Antibody Production Market Size by Application
5.1 Global Antibody Production Historic Market Review by Application (2017-2022)
5.1.1 Global Antibody Production Sales Market Share by Application (2017-2022)
5.1.2 Global Antibody Production Revenue Market Share by Application (2017-2022)
5.1.3 Antibody Production Price by Application (2017-2022)
5.2 Global Antibody Production Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Antibody Production Sales Forecast by Application (2023-2028)
5.2.2 Global Antibody Production Revenue Forecast by Application (2023-2028)
5.2.3 Antibody Production Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antibody Production Sales Breakdown by Company
6.1.1 North America Antibody Production Sales by Company (2017-2022)
6.1.2 North America Antibody Production Revenue by Company (2017-2022)
6.2 North America Antibody Production Market Size by Type
6.2.1 North America Antibody Production Sales by Type (2017-2028)
6.2.2 North America Antibody Production Revenue by Type (2017-2028)
6.3 North America Antibody Production Market Size by Application
6.3.1 North America Antibody Production Sales by Application (2017-2028)
6.3.2 North America Antibody Production Revenue by Application (2017-2028)
6.4 North America Antibody Production Market Size by Country
6.4.1 North America Antibody Production Sales by Country (2017-2028)
6.4.2 North America Antibody Production Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antibody Production Sales Breakdown by Company
7.1.1 Europe Antibody Production Sales by Company (2017-2022)
7.1.2 Europe Antibody Production Revenue by Company (2017-2022)
7.2 Europe Antibody Production Market Size by Type
7.2.1 Europe Antibody Production Sales by Type (2017-2028)
7.2.2 Europe Antibody Production Revenue by Type (2017-2028)
7.3 Europe Antibody Production Market Size by Application
7.3.1 Europe Antibody Production Sales by Application (2017-2028)
7.3.2 Europe Antibody Production Revenue by Application (2017-2028)
7.4 Europe Antibody Production Market Size by Country
7.4.1 Europe Antibody Production Sales by Country (2017-2028)
7.4.2 Europe Antibody Production Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antibody Production Sales Breakdown by Company
8.1.1 Asia Pacific Antibody Production Sales by Company (2017-2022)
8.1.2 Asia Pacific Antibody Production Revenue by Company (2017-2022)
8.2 Asia Pacific Antibody Production Market Size by Type
8.2.1 Asia Pacific Antibody Production Sales by Type (2017-2028)
8.2.2 Asia Pacific Antibody Production Revenue by Type (2017-2028)
8.3 Asia Pacific Antibody Production Market Size by Application
8.3.1 Asia Pacific Antibody Production Sales by Application (2017-2028)
8.3.2 Asia Pacific Antibody Production Revenue by Application (2017-2028)
8.4 Asia Pacific Antibody Production Market Size by Region
8.4.1 Asia Pacific Antibody Production Sales by Region
8.4.2 Asia Pacific Antibody Production Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Antibody Production Sales Breakdown by Company
9.1.1 Latin America Antibody Production Sales by Company (2017-2022)
9.1.2 Latin America Antibody Production Revenue by Company (2017-2022)
9.2 Latin America Antibody Production Market Size by Type
9.2.1 Latin America Antibody Production Sales by Type (2017-2028)
9.2.2 Latin America Antibody Production Revenue by Type (2017-2028)
9.3 Latin America Antibody Production Market Size by Application
9.3.1 Latin America Antibody Production Sales by Application (2017-2028)
9.3.2 Latin America Antibody Production Revenue by Application (2017-2028)
9.4 Latin America Antibody Production Market Size by Country
9.4.1 Latin America Antibody Production Sales by Country (2017-2028)
9.4.2 Latin America Antibody Production Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antibody Production Sales Breakdown by Company
10.1.1 Middle East and Africa Antibody Production Sales by Company (2017-2022)
10.1.2 Middle East and Africa Antibody Production Revenue by Company (2017-2022)
10.2 Middle East and Africa Antibody Production Market Size by Type
10.2.1 Middle East and Africa Antibody Production Sales by Type (2017-2028)
10.2.2 Middle East and Africa Antibody Production Revenue by Type (2017-2028)
10.3 Middle East and Africa Antibody Production Market Size by Application
10.3.1 Middle East and Africa Antibody Production Sales by Application (2017-2028)
10.3.2 Middle East and Africa Antibody Production Revenue by Application (2017-2028)
10.4 Middle East and Africa Antibody Production Market Size by Country
10.4.1 Middle East and Africa Antibody Production Sales by Country (2017-2028)
10.4.2 Middle East and Africa Antibody Production Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Corporation Information
11.1.2 Thermo Fisher Scientific, Inc. Overview
11.1.3 Thermo Fisher Scientific, Inc. Antibody Production Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Thermo Fisher Scientific, Inc. Antibody Production Products and Services
11.1.5 Thermo Fisher Scientific, Inc. Antibody Production SWOT Analysis
11.1.6 Thermo Fisher Scientific, Inc. Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Corporation Information
11.2.2 GE Healthcare Overview
11.2.3 GE Healthcare Antibody Production Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 GE Healthcare Antibody Production Products and Services
11.2.5 GE Healthcare Antibody Production SWOT Analysis
11.2.6 GE Healthcare Recent Developments
11.3 Sartorius AG
11.3.1 Sartorius AG Corporation Information
11.3.2 Sartorius AG Overview
11.3.3 Sartorius AG Antibody Production Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Sartorius AG Antibody Production Products and Services
11.3.5 Sartorius AG Antibody Production SWOT Analysis
11.3.6 Sartorius AG Recent Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Corporation Information
11.4.2 Merck KGaA Overview
11.4.3 Merck KGaA Antibody Production Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Merck KGaA Antibody Production Products and Services
11.4.5 Merck KGaA Antibody Production SWOT Analysis
11.4.6 Merck KGaA Recent Developments
11.5 Eppendorf AG
11.5.1 Eppendorf AG Corporation Information
11.5.2 Eppendorf AG Overview
11.5.3 Eppendorf AG Antibody Production Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Eppendorf AG Antibody Production Products and Services
11.5.5 Eppendorf AG Antibody Production SWOT Analysis
11.5.6 Eppendorf AG Recent Developments
11.6 Cellab GmbH
11.6.1 Cellab GmbH Corporation Information
11.6.2 Cellab GmbH Overview
11.6.3 Cellab GmbH Antibody Production Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Cellab GmbH Antibody Production Products and Services
11.6.5 Cellab GmbH Antibody Production SWOT Analysis
11.6.6 Cellab GmbH Recent Developments
11.7 Pall Corp.
11.7.1 Pall Corp. Corporation Information
11.7.2 Pall Corp. Overview
11.7.3 Pall Corp. Antibody Production Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Pall Corp. Antibody Production Products and Services
11.7.5 Pall Corp. Antibody Production SWOT Analysis
11.7.6 Pall Corp. Recent Developments
11.8 INTEGRA Biosciences AG
11.8.1 INTEGRA Biosciences AG Corporation Information
11.8.2 INTEGRA Biosciences AG Overview
11.8.3 INTEGRA Biosciences AG Antibody Production Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 INTEGRA Biosciences AG Antibody Production Products and Services
11.8.5 INTEGRA Biosciences AG Antibody Production SWOT Analysis
11.8.6 INTEGRA Biosciences AG Recent Developments
11.9 FiberCell Systems Inc.
11.9.1 FiberCell Systems Inc. Corporation Information
11.9.2 FiberCell Systems Inc. Overview
11.9.3 FiberCell Systems Inc. Antibody Production Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 FiberCell Systems Inc. Antibody Production Products and Services
11.9.5 FiberCell Systems Inc. Antibody Production SWOT Analysis
11.9.6 FiberCell Systems Inc. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Antibody Production Value Chain Analysis
12.2 Antibody Production Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibody Production Production Mode & Process
12.4 Antibody Production Sales and Marketing
12.4.1 Antibody Production Sales Channels
12.4.2 Antibody Production Distributors
12.5 Antibody Production Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Antibody Production Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Polyclonal antibody
Table 3. Major Manufacturers of Monoclonal antibody
Table 4. Major Manufacturers of Murine
Table 5. Major Manufacturers of Chimeric
Table 6. Major Manufacturers of Humanized
Table 7. Global Antibody Production Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Antibody Production Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Antibody Production Sales by Region (2017-2022) & (K MT)
Table 10. Global Antibody Production Sales Market Share by Region (2017-2022)
Table 11. Global Antibody Production Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Antibody Production Revenue Market Share by Region (2017-2022)
Table 13. Global Antibody Production Sales Forecast by Region (2023-2028) & (K MT)
Table 14. Global Antibody Production Sales Market Share Forecast by Region (2023-2028)
Table 15. Global Antibody Production Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 16. Global Antibody Production Revenue Market Share Forecast by Region (2023-2028)
Table 17. Top Antibody Production Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 18. Antibody Production Market Trends
Table 19. Antibody Production Market Drivers
Table 20. Antibody Production Market Challenges
Table 21. Antibody Production Market Restraints
Table 22. Global Antibody Production Sales by Manufacturers (2017-2022) & (K MT)
Table 23. Global Antibody Production Sales Share by Manufacturers (2017-2022)
Table 24. Global Antibody Production Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Ranking of Global Top Antibody Production Manufacturers by Revenue (US$ Million) in 2021
Table 26. Antibody Production Revenue Share by Manufacturers (2017-2022)
Table 27. Global Antibody Production Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Production as of 2021)
Table 29. Key Manufacturers Antibody Production Average Selling Price (ASP) & (2017-2022) & (USD/MT)
Table 30. Key Manufacturers Antibody Production Plants/Factories Distribution
Table 31. Key Manufacturers Antibody Production Area Served
Table 32. Date of Key Manufacturers Enter into Antibody Production Market
Table 33. Key Manufacturers Antibody Production Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Antibody Production Sales (K MT) by Type (2017-2022)
Table 36. Global Antibody Production Sales Share by Type (2017-2022)
Table 37. Global Antibody Production Revenue (US$ Million) Market Share by Type (2017-2022)
Table 38. Global Antibody Production Price (K MT) by Type (2017-2022)
Table 39. Global Antibody Production Sales (K MT) by Type (2023-2028)
Table 40. Global Antibody Production Sales Share by Type (2023-2028)
Table 41. Global Antibody Production Revenue (US$ Million) Market Share by Type (2023-2028)
Table 42. Global Antibody Production Revenue Share by Type (2023-2028)
Table 43. Global Antibody Production Price (K MT) by Type (2023-2028)
Table 44. Global Antibody Production Sales (K MT) by Application (2017-2022)
Table 45. Global Antibody Production Sales Share by Application (2017-2022)
Table 46. Global Antibody Production Revenue (US$ Million) Market Share by Application (2017-2022)
Table 47. Global Antibody Production Price (K MT) by Application (2017-2022)
Table 48. Global Antibody Production Sales (K MT) by Application (2023-2028)
Table 49. Global Antibody Production Sales Share by Application (2023-2028)
Table 50. Global Antibody Production Revenue (US$ Million) Market Share by Application (2023-2028)
Table 51. Global Antibody Production Revenue Share by Application (2023-2028)
Table 52. Global Antibody Production Price (K MT) by Application (2023-2028)
Table 53. North America Antibody Production Sales by Company (2017-2022) & (K MT)
Table 54. North America Antibody Production Sales Market Share by Company (2017-2022)
Table 55. North America Antibody Production Revenue by Company (2017-2022) & (US$ Million)
Table 56. North America Antibody Production Revenue Market Share by Company (2017-2022)
Table 57. North America Antibody Production Sales by Type (2017-2022) & (K MT)
Table 58. North America Antibody Production Sales by Type (2023-2028) & (K MT)
Table 59. North America Antibody Production Revenue by Type (2017-2022) & (US$ Million)
Table 60. North America Antibody Production Revenue by Type (2023-2028) & (US$ Million)
Table 61. North America Antibody Production Sales by Application (2017-2022) & (K MT)
Table 62. North America Antibody Production Sales by Application (2023-2028) & (K MT)
Table 63. North America Antibody Production Revenue by Application (2017-2022) & (US$ Million)
Table 64. North America Antibody Production Revenue by Application (2023-2028) & (US$ Million)
Table 65. North America Antibody Production Sales by Country (2017-2022) & (K MT)
Table 66. North America Antibody Production Sales by Country (2023-2028) & (K MT)
Table 67. North America Antibody Production Revenue by Country (2017-2022) & (US$ Million)
Table 68. North America Antibody Production Revenue by Country (2023-2028) & (US$ Million)
Table 69. Europe Antibody Production Sales by Company (2017-2022) & (K MT)
Table 70. Europe Antibody Production Sales Market Share by Company (2017-2022)
Table 71. Europe Antibody Production Revenue by Company (2017-2022) & (US$ Million)
Table 72. Europe Antibody Production Revenue Market Share by Company (2017-2022)
Table 73. Europe Antibody Production Sales by Type (2017-2022) & (K MT)
Table 74. Europe Antibody Production Sales by Type (2023-2028) & (K MT)
Table 75. Europe Antibody Production Revenue by Type (2017-2022) & (US$ Million)
Table 76. Europe Antibody Production Revenue by Type (2023-2028) & (US$ Million)
Table 77. Europe Antibody Production Sales by Application (2017-2022) & (K MT)
Table 78. Europe Antibody Production Sales by Application (2023-2028) & (K MT)
Table 79. Europe Antibody Production Revenue by Application (2017-2022) & (US$ Million)
Table 80. Europe Antibody Production Revenue by Application (2023-2028) & (US$ Million)
Table 81. Europe Antibody Production Sales by Country (2017-2022) & (K MT)
Table 82. Europe Antibody Production Sales by Country (2023-2028) & (K MT)
Table 83. Europe Antibody Production Revenue by Country (2017-2022) & (US$ Million)
Table 84. Europe Antibody Production Revenue by Country (2023-2028) & (US$ Million)
Table 85. Asia Pacific Antibody Production Sales by Company (2017-2022) & (K MT)
Table 86. Asia Pacific Antibody Production Sales Market Share by Company (2017-2022)
Table 87. Asia Pacific Antibody Production Revenue by Company (2017-2022) & (US$ Million)
Table 88. Asia Pacific Antibody Production Revenue Market Share by Company (2017-2022)
Table 89. Asia Pacific Antibody Production Sales by Type (2017-2022) & (K MT)
Table 90. Asia Pacific Antibody Production Sales by Type (2023-2028) & (K MT)
Table 91. Asia Pacific Antibody Production Revenue by Type (2017-2022) & (US$ Million)
Table 92. Asia Pacific Antibody Production Revenue by Type (2023-2028) & (US$ Million)
Table 93. Asia Pacific Antibody Production Sales by Application (2017-2022) & (K MT)
Table 94. Asia Pacific Antibody Production Sales by Application (2023-2028) & (K MT)
Table 95. Asia Pacific Antibody Production Revenue by Application (2017-2022) & (US$ Million)
Table 96. Asia Pacific Antibody Production Revenue by Application (2023-2028) & (US$ Million)
Table 97. Asia Pacific Antibody Production Sales by Region (2017-2022) & (K MT)
Table 98. Asia Pacific Antibody Production Sales by Region (2023-2028) & (K MT)
Table 99. Asia Pacific Antibody Production Revenue by Region (2017-2022) & (US$ Million)
Table 100. Asia Pacific Antibody Production Revenue by Region (2023-2028) & (US$ Million)
Table 101. Latin America Antibody Production Sales by Company (2017-2022) & (K MT)
Table 102. Latin America Antibody Production Sales Market Share by Company (2017-2022)
Table 103. Latin America Antibody Production Revenue by Company (2017-2022) & (US$ Million)
Table 104. Latin America Antibody Production Revenue Market Share by Company (2017-2022)
Table 105. Latin America Antibody Production Sales by Type (2017-2022) & (K MT)
Table 106. Latin America Antibody Production Sales by Type (2023-2028) & (K MT)
Table 107. Latin America Antibody Production Revenue by Type (2017-2022) & (US$ Million)
Table 108. Latin America Antibody Production Revenue by Type (2023-2028) & (US$ Million)
Table 109. Latin America Antibody Production Sales by Application (2017-2022) & (K MT)
Table 110. Latin America Antibody Production Sales by Application (2023-2028) & (K MT)
Table 111. Latin America Antibody Production Revenue by Application (2017-2022) & (US$ Million)
Table 112. Latin America Antibody Production Revenue by Application (2023-2028) & (US$ Million)
Table 113. Latin America Antibody Production Sales by Country (2017-2022) & (K MT)
Table 114. Latin America Antibody Production Sales by Country (2023-2028) & (K MT)
Table 115. Latin America Antibody Production Revenue by Country (2017-2022) & (US$ Million)
Table 116. Latin America Antibody Production Revenue by Country (2023-2028) & (US$ Million)
Table 117. Middle East and Africa Antibody Production Sales by Company (2017-2022) & (K MT)
Table 118. Middle East and Africa Antibody Production Sales Market Share by Company (2017-2022)
Table 119. Middle East and Africa Antibody Production Revenue by Company (2017-2022) & (US$ Million)
Table 120. Middle East and Africa Antibody Production Revenue Market Share by Company (2017-2022)
Table 121. Middle East and Africa Antibody Production Sales by Type (2017-2022) & (K MT)
Table 122. Middle East and Africa Antibody Production Sales by Type (2023-2028) & (K MT)
Table 123. Middle East and Africa Antibody Production Revenue by Type (2017-2022) & (US$ Million)
Table 124. Middle East and Africa Antibody Production Revenue by Type (2023-2028) & (US$ Million)
Table 125. Middle East and Africa Antibody Production Sales by Application (2017-2022) & (K MT)
Table 126. Middle East and Africa Antibody Production Sales by Application (2023-2028) & (K MT)
Table 127. Middle East and Africa Antibody Production Revenue by Application (2017-2022) & (US$ Million)
Table 128. Middle East and Africa Antibody Production Revenue by Application (2023-2028) & (US$ Million)
Table 129. Middle East and Africa Antibody Production Sales by Country (2017-2022) & (K MT)
Table 130. Middle East and Africa Antibody Production Sales by Country (2023-2028) & (K MT)
Table 131. Middle East and Africa Antibody Production Revenue by Country (2017-2022) & (US$ Million)
Table 132. Middle East and Africa Antibody Production Revenue by Country (2023-2028) & (US$ Million)
Table 133. Thermo Fisher Scientific, Inc. Corporation Information
Table 134. Thermo Fisher Scientific, Inc. Description and Overview
Table 135. Thermo Fisher Scientific, Inc. Antibody Production Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 136. Thermo Fisher Scientific, Inc. Antibody Production Product and Services
Table 137. Thermo Fisher Scientific, Inc. Antibody Production SWOT Analysis
Table 138. Thermo Fisher Scientific, Inc. Recent Developments
Table 139. GE Healthcare Corporation Information
Table 140. GE Healthcare Description and Overview
Table 141. GE Healthcare Antibody Production Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 142. GE Healthcare Antibody Production Product and Services
Table 143. GE Healthcare Antibody Production SWOT Analysis
Table 144. GE Healthcare Recent Developments
Table 145. Sartorius AG Corporation Information
Table 146. Sartorius AG Description and Overview
Table 147. Sartorius AG Antibody Production Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 148. Sartorius AG Antibody Production Product and Services
Table 149. Sartorius AG Antibody Production SWOT Analysis
Table 150. Sartorius AG Recent Developments
Table 151. Merck KGaA Corporation Information
Table 152. Merck KGaA Description and Overview
Table 153. Merck KGaA Antibody Production Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 154. Merck KGaA Antibody Production Product and Services
Table 155. Merck KGaA Antibody Production SWOT Analysis
Table 156. Merck KGaA Recent Developments
Table 157. Eppendorf AG Corporation Information
Table 158. Eppendorf AG Description and Overview
Table 159. Eppendorf AG Antibody Production Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 160. Eppendorf AG Antibody Production Product and Services
Table 161. Eppendorf AG Antibody Production SWOT Analysis
Table 162. Eppendorf AG Recent Developments
Table 163. Cellab GmbH Corporation Information
Table 164. Cellab GmbH Description and Overview
Table 165. Cellab GmbH Antibody Production Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 166. Cellab GmbH Antibody Production Product and Services
Table 167. Cellab GmbH Antibody Production SWOT Analysis
Table 168. Cellab GmbH Recent Developments
Table 169. Pall Corp. Corporation Information
Table 170. Pall Corp. Description and Overview
Table 171. Pall Corp. Antibody Production Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 172. Pall Corp. Antibody Production Product and Services
Table 173. Pall Corp. Antibody Production SWOT Analysis
Table 174. Pall Corp. Recent Developments
Table 175. INTEGRA Biosciences AG Corporation Information
Table 176. INTEGRA Biosciences AG Description and Overview
Table 177. INTEGRA Biosciences AG Antibody Production Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 178. INTEGRA Biosciences AG Antibody Production Product and Services
Table 179. INTEGRA Biosciences AG Antibody Production SWOT Analysis
Table 180. INTEGRA Biosciences AG Recent Developments
Table 181. FiberCell Systems Inc. Corporation Information
Table 182. FiberCell Systems Inc. Description and Overview
Table 183. FiberCell Systems Inc. Antibody Production Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 184. FiberCell Systems Inc. Antibody Production Product and Services
Table 185. FiberCell Systems Inc. Antibody Production SWOT Analysis
Table 186. FiberCell Systems Inc. Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Antibody Production Distributors List
Table 190. Antibody Production Customers List
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Production Product Picture
Figure 2. Global Antibody Production Sales Market Share by Type in 2021 & 2028
Figure 3. Polyclonal antibody Product Picture
Figure 4. Monoclonal antibody Product Picture
Figure 5. Murine Product Picture
Figure 6. Chimeric Product Picture
Figure 7. Humanized Product Picture
Figure 8. Global Antibody Production Sales Market Share by Application in 2021 & 2028
Figure 9. Pharmaceutical and biotechnology companies Use Case
Figure 10. Research laboratories Use Case
Figure 11. Others Use Case
Figure 12. Antibody Production Report Years Considered
Figure 13. Global Antibody Production Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Antibody Production Market Size 2017-2028 (US$ Million)
Figure 15. Global Antibody Production Sales (2017-2022) & (K MT)
Figure 16. Global Antibody Production Market Size Market Share by Region: 2021 VS 2028
Figure 17. Global Antibody Production Sales Market Share by Region (2017-2022)
Figure 18. Global Antibody Production Sales Market Share by Region in 2021
Figure 19. Global Antibody Production Revenue Market Share by Region in 2017 VS 2021
Figure 20. Global Antibody Production Sales Share by Manufacturers in 2021
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody Production Sales in 2021
Figure 22. Antibody Production Revenue Share by Manufacturers in 2021
Figure 23. Antibody Production Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 24. Global Antibody Production Revenue Share by Type (2017-2022)
Figure 25. Global Antibody Production Revenue Growth Rate by Type in 2017 & 2021
Figure 26. Global Antibody Production Revenue Share by Application (2017-2022)
Figure 27. Global Antibody Production Revenue Growth Rate by Application in 2017 & 2021
Figure 28. North America Antibody Production Sales Market Share by Type (2017-2028)
Figure 29. North America Antibody Production Revenue Market Share by Type (2017-2028)
Figure 30. North America Antibody Production Sales Market Share by Application (2017-2028)
Figure 31. North America Antibody Production Revenue Market Share by Application (2017-2028)
Figure 32. North America Antibody Production Sales Share by Country (2
  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs